Companies: 10,795·Total market cap: $144.5T
Kiora Pharmaceuticals, Inc.

Kiora Pharmaceuticals, Inc.

KPRXNASDAQHealthcare● Active
$2.58
+$0.08(+3.20%)
Market Cap$11434405
P/E Ratio
52W High$3.39
52W Low$1.765

Kiora Pharmaceuticals, Inc. (KPRX) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · KPRX · as of Jun 9, 2026

Activity summary

Buy transactions

5

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

Buy/Sell (by trades)

Overall sentiment

BULLISH
↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

Kiora Pharmaceuticals, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

KPRX insider buying and selling by quarter

KPRX insider selling · KPRX insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
531K265K0
2024 Q3
2025 Q2
2026 Q1
2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · KPRX ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

KPRX executive sell shares · KPRX board member insider trading · KPRX insider trading SEC filing

Showing 39 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Tosca Melissa

CFO

Other

Date

Apr 1

Shares

929

Price

$1.95

Value

$2K

View Form 4 on SEC.gov

Daniels Eric Joseph

Chief Development Officer

Other

Date

Apr 1

Shares

929

Price

$1.95

Value

$2K

View Form 4 on SEC.gov

Strem Brian M.

President and CEO · Director

Other

Date

Apr 1

Shares

1,906

Price

$1.95

Value

$4K

View Form 4 on SEC.gov

Daniels Eric Joseph

Chief Development Officer

Award

Date

Mar 6

Shares

6,533

Price

Value

View Form 4 on SEC.gov

Strem Brian M.

President and CEO · Director

Award

Date

Mar 6

Shares

16,733

Price

Value

View Form 4 on SEC.gov

Tosca Melissa

CFO

Award

Date

Mar 6

Shares

6,533

Price

Value

View Form 4 on SEC.gov

Daniels Eric Joseph

Chief Development Officer

Other

Date

Mar 3

Shares

238

Price

$2.02

Value

$481

View Form 4 on SEC.gov

Strem Brian M.

President and CEO · Director

Other

Date

Mar 3

Shares

238

Price

$2.02

Value

$481

View Form 4 on SEC.gov

Tosca Melissa

CFO

Award

Date

Apr 1

Shares

7,772

Price

Value

View Form 4 on SEC.gov

Daniels Eric Joseph

Chief Development Officer

Award

Date

Apr 1

Shares

7,772

Price

Value

View Form 4 on SEC.gov

Strem Brian M.

President and CEO · Director

Award

Date

Apr 1

Shares

15,941

Price

Value

View Form 4 on SEC.gov

Stengone Carmine N.

Director

Purchase

Date

Sep 11

Shares

1,250

Price

$3.68

Value

$5K

View Form 4 on SEC.gov

Shapiro Aron

Director

Purchase

Date

Sep 10

Shares

3,000

Price

$3.60

Value

$11K

View Form 4 on SEC.gov

Walters-Hoffert Lisa

Director

Purchase

Date

Aug 19

Shares

1,250

Price

$3.86

Value

$5K

View Form 4 on SEC.gov

TYLE PRAVEEN

Director

Purchase

Date

Aug 19

Shares

5,000

Price

$3.96

Value

$20K

View Form 4 on SEC.gov

Tosca Melissa

CFO

Purchase

Date

Aug 14

Shares

2,000

Price

$3.21

Value

$6K

View Form 4 on SEC.gov

Strem Brian M.

President and CEO · Director

Award

Date

Jul 1

Shares

15,629

Price

Value

View Form 4 on SEC.gov

Tosca Melissa

CFO

Award

Date

Jul 1

Shares

7,620

Price

Value

View Form 4 on SEC.gov

Daniels Eric Joseph

Chief Development Officer

Award

Date

Jul 1

Shares

7,355

Price

Value

View Form 4 on SEC.gov

Tosca Melissa

EVP Finance

Purchase

Date

Jun 14

Shares

100

Price

$5.25

Value

$525

View Form 4 on SEC.gov

Daniels Eric Joseph

Chief Development Officer

Purchase

Date

Jun 14

Shares

1,431

Price

$5.29

Value

$8K

View Form 4 on SEC.gov

Parsons Erin

Director

Purchase

Date

Jun 13

Shares

5,260

Price

$4.88

Value

$26K

View Form 4 on SEC.gov

Strem Brian M.

President and CEO · Director

Purchase

Date

Jun 13

Shares

3,000

Price

$5.00

Value

$15K

View Form 4 on SEC.gov

Tosca Melissa

EVP Finance

Award

Date

Sep 29

Shares

30,000

Price

Value

View Form 4 on SEC.gov

Daniels Eric Joseph

Chief Development Officer

Award

Date

Sep 29

Shares

62,500

Price

Value

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About KPRX insider trading

KPRX insider trades

Kiora Pharmaceuticals, Inc. (KPRX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Daniels Eric Joseph (Chief Development Officer), Strem Brian M. (President and CEO · Director), Tosca Melissa (CFO). Over the past 12 months, 3 insiders have filed transactions with the SEC. KPRX insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Kiora Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

KPRX insider trading · 5 questions

The insiders of Kiora Pharmaceuticals, Inc. (KPRX) include executives and directors such as Daniels Eric Joseph (Chief Development Officer), Strem Brian M. (President and CEO · Director), Tosca Melissa (CFO), among others. Over the past 12 months, 3 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

KPRX board member insider tradingwho are KPRX insidersKPRX insider rosterKiora Pharmaceuticals, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026